Form 4 Filing for Beta Bionics, Inc. - Officer/Director Stock Transaction

This filing details a stock transaction by Danny L. Dearen, a director at Beta Bionics, Inc. On May 21, 2026, 16,965 restricted stock units were awarded under the Issuer's 2025 Equity Incentive Plan. This award was granted at a transaction price of $0.00 per share. Following this transaction, Mr. Dearen now owns 32,209 shares, with ownership designated as direct.